Russia’s Sputnik V vaccine 91.6% effective in late-stage trial

Russia’s Sputnik V vaccine was 91.6% effective in preventing people from developing COVID-19, according to peer-reviewed results from its late-stage clinical trial published in The Lancent international medical journal on…